Tuesday, August 15, 2017 2:56:50 PM
jonblair77 Friday, 12/02/16 08:10:07 PM
Re: 4u2nv2 post# 190119
Post #
190120
of 193655 Go
There are a few holders/buyers who believe they will get the drug through trials and this is a $1+ stock. When the stock drops to trips they buy shares
for the run they believe will come.
Lots of the old holders did this prior to the stock going to a dime during the Bio harp run. Many of them made a huge amount of cash.
I won't buy anymore shares, but have been holding. That is why I say always say I am holding for boom or bust. This stock has done well for me in the past few runs. I don't know if it will again, but if you do research you can do the math to understand that if the drug gets through trials(long shot), this could easily be a $2 stock. For some the chance of retirement is worth the gamble to buy in the trips.
So 10M shares at 001 is 10K for the potential return in about a year after trials start is maybe 15 to 25 million, some of the holder/buyers here will say more than than that...,, so the risk vs reward here is "worth it" for them!
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM